Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -53.83 | N/A |
| PEG Ratio (TTM) | 0.31 | N/A |
| P/S Ratio (TTM) | 1.23 | N/A |
| P/B Ratio (TTM) | 0.74 | N/A |
| P/FCF Ratio (TTM) | -16.02 | N/A |
| Price to 5YR AVG Earnings Ratio | -8.84 | N/A |
| Price to 5YR AVG FCF Ratio | -15.68 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.20% | N/A |
| ROE (TTM) | -1.37% | N/A |
| Net Profit Margin (TTM) | -2.29% | N/A |
| ROIC 5YR AVG | -17.70% | N/A |
Growth (5%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -49.10% | -8,806.24% | -5,833.94% |
| Revenue | 2.78% | -21.50% | -10.59% |
| Net Income | -49.03% | -9,264.17% | -6,113.91% |
| Cash Flow | -90.85% | -6.85% | -109.53% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.82 | N/A |
| Quick Ratio (TTM) | 5.73 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | -564.50 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 0.91 | N/A |
| LTL to 5YR AVG FCF | -0.26 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.92% | N/A |